期刊
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
卷 58, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jddst.2019.101395
关键词
Amorphous solid dispersions; Hydroxyl propyl methyl cellulose acetate succinate; Glass transition temperature; Hot melt extrusion; Stability
资金
- National Institute of General Medical Sciences [P20GM104932]
- Biopharmaceutics-Clinical and Translational Core E of the COBRE, a component of the National Institutes of Health
Development of stable amorphous solid dispersions (ASDs) for a low glass transition temperature (Tg) drug is a challenging task. The physico-chemical properties of the drug and excipients play a critical role in developing stable ASDs. In this study, ASDs of poorly soluble fenofibrate, a drug with a low Tg, were formulated using hydroxy propyl methylcellulose acetate succinate (HPMCAS) via hot melt extrusion (HME). The feasible pro-cessing conditions were established at varying drug loads and processing temperatures. The prepared ASDs were characterized for crystallinity using differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). Fourier transform-infrared spectroscopy was performed to study the potential interactions. DSC and PXRD studies confirmed the amorphous state of fenofibrate in the prepared ASDs. A discriminative in vitro dissolution method was established to study the impact of HPMCAS grades on dissolution profile. The dissolution parameters such as dissolution efficiency, initial dissolution rate and mean dissolution rate, suggested improved dissolution characteristics compared to pure fenofibrate. Accelerated stability studies at 40 degrees C/75% RH showed preservation of the amorphous nature of fenofibrate in formulations with 15% drug load and in vitro drug release studies indicated similar release profiles (f2 > 50). This study provides an insight into the formulation and processing of ASDs for poorly soluble drugs with low Tg.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据